Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · Real-Time Price · USD
1.990
+0.045 (2.31%)
At close: Mar 9, 2026, 4:00 PM EDT
1.910
-0.080 (-4.02%)
After-hours: Mar 9, 2026, 7:43 PM EDT
Enveric Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 3 | 4 | 3 | 4 | 29 | 135,206 | |
| Market Cap Growth | 5.88% | 20.78% | -30.19% | -85.19% | -99.98% | - | |
| Enterprise Value | -1 | 1 | -1 | -16 | 8 | 135,208 | |
| Last Close Price | 1.95 | 64.51 | 234.00 | 374.40 | 8370.00 | 38340.00 | |
| PB Ratio | 0.29 | 2.29 | 1.54 | 0.28 | 1.31 | 39584.39 | |
| P/TBV Ratio | 0.76 | 2.35 | 1.73 | 0.30 | 2.12 | 86384.49 | |
| Debt / Equity Ratio | - | - | - | 0.00 | 0.01 | - | |
| Net Debt / Equity Ratio | -1.09 | -1.41 | -1.17 | -1.13 | -0.77 | -0.46 | |
| Net Debt / EBITDA Ratio | 0.40 | 0.24 | 0.14 | 0.90 | 0.70 | 0.29 | |
| Net Debt / FCF Ratio | 0.49 | 0.29 | 0.16 | 1.00 | 1.48 | 0.41 | |
| Quick Ratio | 4.15 | 1.50 | 1.07 | 4.43 | 8.33 | 2.32 | |
| Current Ratio | 4.60 | 1.84 | 1.53 | 4.61 | 8.51 | 3.35 | |
| Return on Equity (ROE) | -262.78% | -539.57% | -197.47% | -97.57% | -380.82% | -855.92% | |
| Return on Assets (ROA) | -133.22% | -163.09% | -86.20% | -53.92% | -102.60% | -166.96% | |
| Return on Capital Employed (ROCE) | -282.20% | -604.70% | -840.80% | -128.30% | -102.70% | -164.50% | |
| Earnings Yield | -427.97% | -262.70% | -573.02% | -427.33% | -167.81% | -0.01% | |
| FCF Yield | -291.82% | -211.97% | -467.23% | -410.21% | -39.91% | -0.00% | |
| Buyback Yield / Dilution | -484.62% | -249.38% | - | - | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.